4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 5g

4-Ethoxyphenyl isocyanate, 98.0%, 5g

11-Chloro-7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline, 95+%, 5g

3-Aminothietane 1,1-dioxide, 95.0%, 1g

(R)-1-(4-Chloro-2-fluorophenyl)ethan-1-amine hydrochloride, 95%, 1g

1,4-Phénylènediamine, min.99%, pour la synthèse, 250 g, emballage en verre

(1R*,4R*)-4-(3-Aminopyridin-2-ylamino)cyclohexanol, 1g

LETERMOVIR, 95%, 10mg

(3aR,5R,6R,6aR)-5-(Hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol, 98%, 25g

N-t-Butylpiperazine, 95.0%, 250mg

6-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg

Decafluorobenzhydrol, 97.0%, 25g

(2-Amino-5-bromophenyl)dimethylphosphine oxide, 98%, 10g